51
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Study on mNGS Technique in Diagnosing Pneumocystis jirovecii Pneumonia in Non-HIV-Infected Patients

, , , , &
Pages 1397-1405 | Received 20 Nov 2023, Accepted 07 Feb 2024, Published online: 12 Apr 2024

References

  • Apostolopoulou A, Fishman JA. The pathogenesis and diagnosis of Pneumocystis jiroveci Pneumonia. J Fungi. 2022;8(11):1167. PMID: 36354934; PMCID: PMC9696632. doi:10.3390/jof8111167
  • Bateman M, Oladele R, Kolls JK. Diagnosing pneumocystis jirovecii pneumonia: a review of current methods and novel approaches. Med Mycol. 2020;58(8):1015–1028. PMID: 32400869; PMCID: PMC7657095. doi:10.1093/mmy/myaa024
  • Huang YS, Yang JJ, Lee NY, et al. Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review. Expert Rev Anti Infect Ther. 2017;15(9):873–892. PMID: 28782390. doi:10.1080/14787210.2017.1364991
  • Tang G, Tong S, Yuan X, et al. Using routine laboratory markers and immunological indicators for predicting Pneumocystis jiroveci Pneumonia in immunocompromised patients. Front Immunol. 2021;12:652383. PMID: 33912176; PMCID: PMC8071988. doi:10.3389/fimmu.2021.652383
  • Yang L, Xia P, Zhou Y, et al. Characteristics and risk factors for Pneumocystis jirovecii pneumonia in patients with idiopathic membranous nephropathy. Eur J Clin Microbiol Infect Dis. 2021;40(11):2305–2314. PMID: 34047874. doi:10.1007/s10096-021-04227-0
  • Weyant RB, Kabbani D, Doucette K, et al. Pneumocystis jirovecii: a review with a focus on prevention and treatment. Expert Opin Pharmacother. 2021;22(12):1579–1592. PMID: 33870843. doi:10.1080/14656566.2021.1915989
  • Zhou S, Linder KA, Kauffman CA, et al. Diagnostic performance of bronchoalveolar lavage (1,3)-β-d-glucan assay for Pneumocystis jirovecii Pneumonia. J Fungi. 2020;6(4):200. PMID: 33019729; PMCID: PMC7712134. doi:10.3390/jof6040200
  • Lussac-Sorton F, Fleur T, Voisin T, et al. Interest of a commercialized Pneumocystis jirovecii quantitative PCR to discriminate colonization from Pneumocystis Pneumonia according to the revised EORTC/MSGERC criteria. J Clin Med. 2022;12(1):316. PMID: 36615116; PMCID: PMC9821677. doi:10.3390/jcm12010316
  • Wu X, Li Y, Zhang M, et al. Etiology of severe community-acquired Pneumonia in adults based on metagenomic next-generation sequencing: a Prospective Multicenter Study. Infect Dis Ther. 2020;9(4):1003–1015. PMID: 33170499; PMCID: PMC7652912. doi:10.1007/s40121-020-00353-y
  • Li XQ, Yang CL, Mao YH, et al. The diagnostic value of metagenomic next-generation sequencing in AIDS patients complicated with Pneumocystis jirovecii infection. Chin J Lab Med. 2023;46(2):169–175. doi:10.3760/cma.j.cn114452-20220408-00207
  • Cillóniz C, Dominedò C, Álvarez-Martínez MJ, et al. Pneumocystis pneumonia in the twenty-first century: HIV-infected versus HIV-uninfected patients. Expert Rev Anti Infect Ther. 2019;17(10):787–801. PMID: 31550942. doi:10.1080/14787210.2019.1671823
  • Wang Y, Zhou X, Saimi M, et al. Risk factors of mortality from Pneumocystis Pneumonia in non-HIV patients: a meta-analysis. Front Public Health. 2021;9:680108. PMID: 34222179; PMCID: PMC8244732. doi:10.3389/fpubh.2021.680108
  • Ko Y, Jeong BH, Park HY, et al. Outcomes of Pneumocystis pneumonia with respiratory failure in HIV-negative patients. J Crit Care. 2014;29(3):356–361. PMID: 24440053. doi:10.1016/j.jcrc.2013.12.005
  • Zakrzewska M, Roszkowska R, Zakrzewski M, et al. Pneumocystis Pneumonia: still a serious disease in children. J Mother Child. 2021;23(3):159–162. PMID: 33759428; PMCID: PMC8522405. doi:10.34763/devperiodmed.20192303.159162
  • Salzer HJF, Schäfer G, Hoenigl M, et al. Clinical, diagnostic, and treatment disparities between HIV-infected and non-HIV-infected immunocompromised patients with Pneumocystis jirovecii Pneumonia. Respiration. 2018;96(1):52–65. PMID: 29635251. doi:10.1159/000487713
  • Chagas OJ, Nagatomo PP, Pereira-Chioccola VL, et al. Performance of a real time PCR for Pneumocystis jirovecii identification in induced sputum of AIDS patients: differentiation between Pneumonia and colonization. J Fungi. 2022;8(3):222. PMID: 35330224; PMCID: PMC8950466. doi:10.3390/jof8030222
  • Pan T, Tan R, Qu H, et al. Next-generation sequencing of the BALF in the diagnosis of community-acquired pneumonia in immunocompromised patients. J Infect. 2019;79(1):61–74. PMID: 30476493; PMCID: PMC7133759. doi:10.1016/j.jinf.2018.11.005
  • Yoshida M. Development of a method of measuring β-D-glucan and its use in preemptive therapy for invasive fungal infections. Int J Mol Sci. 2021;22(17):9265. PMID: 34502174; PMCID: PMC8431658. doi:10.3390/ijms22179265
  • Szvalb AD, Malek AE, Jiang Y, et al. Serum (1,3)-Beta-d-glucan has suboptimal performance for the diagnosis of Pneumocystis jirovecii pneumonia in cancer patients and correlates poorly with respiratory burden as measured by quantitative PCR. J Infect. 2020;81(3):443–451. PMID: 32650108. doi:10.1016/j.jinf.2020.07.003
  • Zhang P, Chen Y, Li S, et al. Metagenomic next-generation sequencing for the clinical diagnosis and prognosis of acute respiratory distress syndrome caused by severe pneumonia: a retrospective study. PeerJ. 2020;8:e9623. PMID: 32821543; PMCID: PMC7395598. doi:10.7717/peerj.9623
  • Duan J, Gao J, Liu Q, et al. Characteristics and prognostic factors of non-HIV immunocompromised patients with Pneumocystis Pneumonia diagnosed by metagenomics next-generation sequencing. Front Med Lausanne. 2022;9:812698. PMID: 35308503; PMCID: PMC8928194. doi:10.3389/fmed.2022.812698